HbO2 Therapeutics
Ms. Zafirelis has more than 25 years of pharmaceutical, biotech, and CRO experience. Having spent the majority of that time in smaller companies and startup environments, she has assumed a variety of cross functional roles and responsibilities, resulting in a comprehensive understanding of the regulatory landscape, and an ability to manage complex issues, across a wide range of therapeutic areas. She interacts directly with Regulatory Authorities in both the US and other jurisdictions, for both the human and veterinary products. Her background includes a BA from University of Massachusetts and a MBA from the University of Southern California.
This person is not in any offices
HbO2 Therapeutics
1 followers
Hemoglobin Oxygen Therapeutics LLC (HbO2 Therapeutics) is a leading developer and manufacturer of oxygen-carrying solutions, a class of drug products that when administered intravenously can increase the amount of oxygen transported throughout the body.